Tenderwize
Retour à la recherche

Open House Rebate Agreements Clobetasol

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 552 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Clobetasol, ATC D07AD01

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume – revenue potential unknown. The agreement is non-exclusive and may be superseded by futur...

The agreement automatically terminates if a regular (competitive) rebate contract for the same substance comes into eff...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Provide pharmaceutical products with active substance Clobetasol (ATC D07AD01)
  • Enter into non-exclusive rebate agreement with AOK Bayern
Afficher le résumé complet

This is an open-house (non-competitive) model for non-exclusive rebate agreements on Clobetasol (ATC D07AD01) with AOK Bayern. All interested pharmaceutical companies that meet eligibility criteria can join. Contracts run from 01/05/2026 to 30/04/2028, with possibility of later joining until 03/03/2028. No estimated value provided. No award criteria (no selection). Eligibility requires a signed self-declaration of reliability. Submission can be in paper or electronic with qualified signature. Documents must be requested via the DTVP portal.

Risques

No estimated value or volume – revenue potential unknown. The agreement is non-exclusive and may be superseded by futur...

The agreement automatically terminates if a regular (competitive) rebate contract for the same substance comes into eff...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Eligibility: signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)

Administrative

  • Submission of signed contract, annex listing medicines, and self-declaration
  • Submission via paper (2 original copies) or electronic with qualified electronic signature via DTVP portal

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria (open-house).

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Rebate Agreements Clobetasol

Non-exclusive rebate agreements for pharmaceutical products containing Clobetasol (ATC D07AD01). All eligible companies can join. Framework agreement with no guaranteed volume. Contract duration 24 months (01/05/2026-30/04/2028).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Apr 2026 - Apr 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria (open-house).

Date limite

Deadline Mar 03, 2028

Détails de la procédure

Date de publication
15 Mar 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
181502-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30